Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage

Agnese Collino, Alberto Termanini, Paola Nicoli, Giuseppe Diaferia, Sara Polletti, Camilla Recordati, Vittoria Castiglioni, Donatella Caruso, Nico Mitro, Gioacchino Natoli, Serena Ghisletti

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Chronic inflammation promotes oncogenic transformation and tumor progression. Many inflammatory agents also generate a toxic microenvironment, implying that adaptive mechanisms must be deployed for cells to survive and undergo transformation in such unfavorable contexts. A paradigmatic case is represented by cancers occurring in pediatric patients with genetic defects of hepatocyte phosphatidylcholine transporters and in the corresponding mouse model (Mdr2-/-mice), in which impaired bile salt emulsification leads to chronic hepatocyte damage and inflammation, eventually resulting in oncogenic transformation. By combining genomics and metabolomics, we found that the transition from inflammation to cancer in Mdr2-/-mice was linked to the sustained transcriptional activation of metabolic detoxification systems and transporters by the Constitutive Androstane Receptor (CAR), a hepatocyte-specific nuclear receptor. Activation of CAR-dependent gene expression programs coincided with reduced content of toxic bile acids in cancer nodules relative to inflamed livers. Treatment of Mdr2-/-mice with a CAR inhibitor blocked cancer progression and caused a partial regression of existing tumors. These results indicate that the acquisition of resistance to endo- or xeno-biotic toxicity is critical for cancers that develop in toxic microenvironments.

Original languageEnglish
Article numbere1007380
JournalPLoS Genetics
Volume14
Issue number5
DOIs
Publication statusPublished - May 1 2018

Fingerprint

bile acids
detoxification
Bile Acids and Salts
carcinogenesis
cancer
Carcinogenesis
liver
damage
neoplasms
Liver
acid
Poisons
hepatocytes
Neoplasms
receptors
tumor
inflammation
Hepatocytes
transporters
Inflammation

ASJC Scopus subject areas

  • Ecology, Evolution, Behavior and Systematics
  • Molecular Biology
  • Genetics
  • Genetics(clinical)
  • Cancer Research

Cite this

Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage. / Collino, Agnese; Termanini, Alberto; Nicoli, Paola; Diaferia, Giuseppe; Polletti, Sara; Recordati, Camilla; Castiglioni, Vittoria; Caruso, Donatella; Mitro, Nico; Natoli, Gioacchino; Ghisletti, Serena.

In: PLoS Genetics, Vol. 14, No. 5, e1007380, 01.05.2018.

Research output: Contribution to journalArticle

@article{3ce8ea931ad64f5993c917ffaccee57a,
title = "Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage",
abstract = "Chronic inflammation promotes oncogenic transformation and tumor progression. Many inflammatory agents also generate a toxic microenvironment, implying that adaptive mechanisms must be deployed for cells to survive and undergo transformation in such unfavorable contexts. A paradigmatic case is represented by cancers occurring in pediatric patients with genetic defects of hepatocyte phosphatidylcholine transporters and in the corresponding mouse model (Mdr2-/-mice), in which impaired bile salt emulsification leads to chronic hepatocyte damage and inflammation, eventually resulting in oncogenic transformation. By combining genomics and metabolomics, we found that the transition from inflammation to cancer in Mdr2-/-mice was linked to the sustained transcriptional activation of metabolic detoxification systems and transporters by the Constitutive Androstane Receptor (CAR), a hepatocyte-specific nuclear receptor. Activation of CAR-dependent gene expression programs coincided with reduced content of toxic bile acids in cancer nodules relative to inflamed livers. Treatment of Mdr2-/-mice with a CAR inhibitor blocked cancer progression and caused a partial regression of existing tumors. These results indicate that the acquisition of resistance to endo- or xeno-biotic toxicity is critical for cancers that develop in toxic microenvironments.",
author = "Agnese Collino and Alberto Termanini and Paola Nicoli and Giuseppe Diaferia and Sara Polletti and Camilla Recordati and Vittoria Castiglioni and Donatella Caruso and Nico Mitro and Gioacchino Natoli and Serena Ghisletti",
year = "2018",
month = "5",
day = "1",
doi = "10.1371/journal.pgen.1007380",
language = "English",
volume = "14",
journal = "PLoS Genetics",
issn = "1553-7390",
publisher = "Public Library of Science",
number = "5",

}

TY - JOUR

T1 - Sustained activation of detoxification pathways promotes liver carcinogenesis in response to chronic bile acid-mediated damage

AU - Collino, Agnese

AU - Termanini, Alberto

AU - Nicoli, Paola

AU - Diaferia, Giuseppe

AU - Polletti, Sara

AU - Recordati, Camilla

AU - Castiglioni, Vittoria

AU - Caruso, Donatella

AU - Mitro, Nico

AU - Natoli, Gioacchino

AU - Ghisletti, Serena

PY - 2018/5/1

Y1 - 2018/5/1

N2 - Chronic inflammation promotes oncogenic transformation and tumor progression. Many inflammatory agents also generate a toxic microenvironment, implying that adaptive mechanisms must be deployed for cells to survive and undergo transformation in such unfavorable contexts. A paradigmatic case is represented by cancers occurring in pediatric patients with genetic defects of hepatocyte phosphatidylcholine transporters and in the corresponding mouse model (Mdr2-/-mice), in which impaired bile salt emulsification leads to chronic hepatocyte damage and inflammation, eventually resulting in oncogenic transformation. By combining genomics and metabolomics, we found that the transition from inflammation to cancer in Mdr2-/-mice was linked to the sustained transcriptional activation of metabolic detoxification systems and transporters by the Constitutive Androstane Receptor (CAR), a hepatocyte-specific nuclear receptor. Activation of CAR-dependent gene expression programs coincided with reduced content of toxic bile acids in cancer nodules relative to inflamed livers. Treatment of Mdr2-/-mice with a CAR inhibitor blocked cancer progression and caused a partial regression of existing tumors. These results indicate that the acquisition of resistance to endo- or xeno-biotic toxicity is critical for cancers that develop in toxic microenvironments.

AB - Chronic inflammation promotes oncogenic transformation and tumor progression. Many inflammatory agents also generate a toxic microenvironment, implying that adaptive mechanisms must be deployed for cells to survive and undergo transformation in such unfavorable contexts. A paradigmatic case is represented by cancers occurring in pediatric patients with genetic defects of hepatocyte phosphatidylcholine transporters and in the corresponding mouse model (Mdr2-/-mice), in which impaired bile salt emulsification leads to chronic hepatocyte damage and inflammation, eventually resulting in oncogenic transformation. By combining genomics and metabolomics, we found that the transition from inflammation to cancer in Mdr2-/-mice was linked to the sustained transcriptional activation of metabolic detoxification systems and transporters by the Constitutive Androstane Receptor (CAR), a hepatocyte-specific nuclear receptor. Activation of CAR-dependent gene expression programs coincided with reduced content of toxic bile acids in cancer nodules relative to inflamed livers. Treatment of Mdr2-/-mice with a CAR inhibitor blocked cancer progression and caused a partial regression of existing tumors. These results indicate that the acquisition of resistance to endo- or xeno-biotic toxicity is critical for cancers that develop in toxic microenvironments.

UR - http://www.scopus.com/inward/record.url?scp=85048229189&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048229189&partnerID=8YFLogxK

U2 - 10.1371/journal.pgen.1007380

DO - 10.1371/journal.pgen.1007380

M3 - Article

C2 - 29734330

AN - SCOPUS:85048229189

VL - 14

JO - PLoS Genetics

JF - PLoS Genetics

SN - 1553-7390

IS - 5

M1 - e1007380

ER -